Glucocorticoids aggravate hyperoxia-induced lung injury through decreased nuclear factor-κB activity

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 284, Issue 1 28-1, 2003, Pages

  Barazzone Argiroffo, Constance ^a,b   Pagano, Alessandra ^a   Juge, Cristiana ^a   Métrailler, Isabelle ^a   Rochat, Anne ^a   Vesin, Christian ^a   Donati, Yves ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b Centre Médical Universitaire   (Switzerland)

Author keywords

Apoptosis; Mice; Oxygen; Steroid

Indexed keywords

CORTICOSTERONE; GLUCOCORTICOID; HYDROCORTISONE ACETATE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; RECOMBINANT INTERLEUKIN 6; TRANSCRIPTION FACTOR AP 1;

ADRENALECTOMY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; HYPEROXIA; INFLAMMATION; LUNG INJURY; LUNG LAVAGE; LUNG WEIGHT; MICROSCOPY; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT;

EID: 0037213547     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00239.2002     Document Type: Article

References (45)

1. Allen GL, Menendez IY, Ryan MA, Mazor RL, Wispe JR, Fiedler MA, and Wong HR. Hyperoxia synergistically increases TNF-α-induced interleukin-8 gene expression in A549 ceils. Am J Physiol Lung Cell Mol Physiol 278: L253-L260, 2000.
2. Auphan N, DiDonato JA, Rosette C, Helmberg A, and Karin M. Immunosuppression by glucocorticoids: Inhibition of NF-κB activity through induction of IκB synthesis. Science 270: 286-290, 1995.
3. Bancalari E. Changes in the pathogenesis and prevention of chronic lung disease of prematurity. Am J Perinatol 18: 1-9, 2001.
4. Barazzone C, Belin D, Piguet PF, Vassalli JD, and Sappino AP. Plasminogen activator inhibitor-1 in acute hyperoxic mouse lung injury. J Clin Invest 98: 2666-2673, 1996.
5. Barazzone C, Donati YR, Rochat AF, Vesin C, Laperrousaz CD, Pache JC, and Piguet PF. Keratinocyte growth factor protects both alveolar epithelium and endothelium from oxygen-induced injury in mice. Am J Pathol 154: 1479-1487, 1999.
6. Barazzone C, Tacchini-Cottier F, Vesin C, Rochat AF, and Piguet PF. Hyperoxia induces platelet activation and lung sequestration: An event dependent on tumor necrosis factor-α and CD11a. Am J Respir Cell Mol Biol 15: 107-114, 1996.
7. Barazzone Argiroffo C, Donati YR, Boccard J, Rochat AF, Vesin C, Kan CD, and Piguet PF. CD40-CD40 ligand disruption does not prevent hyperoxia-induced injury. Am J Pathol 160: 67-71, 2002.
8. Barazzone-Argiroffo C, Muzzin P, Donati YR, Kan CD, Aubert ML, and Piguet PF. Hyperoxia increases leptin production: A mechanism mediated through endogenous elevation of corticosterone. Am J Physiol Lung Cell Mol Physiol 281: L1150-L1156, 2001.
9. Bollaert PE, Charpentier C, Levy B, Debouverie M, Audibert G, and Larcan A. Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 26: 645-650, 1998.
10. Burri P. Structural aspects of prenatal and postnatal development and growth of the lung. In: Lung Growth and Development, edited by McDonald JA. New York: Dekker, 1997, p. 1-35.
11. Collard HR and King TE. Treatment of idiopathic pulmonary fibrosis: The rise and fall of corticosteroids. Am J Med 110: 326-328, 2001.
12. Cuzzocrea S, Chatterjee PK, Mazzon E, Dugo L, Serraino I, Britti D, Mazzullo G, Caputi AP, and Thiemermann C. Pyrrolidine dithiocarbamate attenuates the development of acute and chronic inflammation. Br J Pharmacol 135: 496-510, 2002.
13. Dorscheid DR, Wojcik KR, Sun S, Marroquin B, and White SR. Apoptosis of airway epithelial cells induced by corticosteroids. Am J Respir Crit Care Med 164: 1939-1947, 2001.
14. Evans-Storms RB and Cidlowski JA. Delineation of an anti-apoptotic action of glucocorticoids in hepatoma cells: The role of nuclear factor-κB. Endocrinology 141: 1854-1862, 2000.
15. Fox RB, Hiodal JR, Brown DM, and Repine JE. Pulmonary inflammation due to oxygen toxicity: Involvement of chemotactic factors and polymorphonuclear cells. Am Rev Respir Dis 123: 521-523, 1981.
16. Franek WR, Horowitz S, Stansberry L, Kazzaz J, Koo HC, Li Y, Davis JM, Mantell AS, Scott W, and Mantell L. Hyperoxia inhibits oxidant-induced apoptosis in lung epithelial cells. J Biol Chem 276: 569-575, 2001.
17. Ghoshal K, Wang Y, Sheridan JF, and Jacob ST. Metallothionein induction in response to restraint stress. J Biol Chem 273: 27904-27910, 1998.
18. Gilbert KA, Petrovic-Dovat L, and Rannels E. Hormonal control of compensatory lung growth. In: Lung Growth and Development, edited by McDonald JA. New York: Dekker, 1997, p. 627-660.
19. Gorman AM, Hirt UA, Orrenius S, and Ceccatelli S. Dexamethasone pre-treatment interferes with apoptotic death in glioma cells. Neuroscience 96: 417-425, 2000.
20. Lawrence T, Gilroy DW, Colville-Nash PR, and Willoughby DA. Possible new role for NF-κB in the resolution of inflammation. Nat Med 7: 1291-1297, 2001.
21. Li Y, Zhang W, Mantell LL, Kazzaz JA, Fein AF, and Horowitz S. Nuclear factor-κB is activated by hyperoxia but does not protect from cell death. J Biol Chem 272: 20646-20649, 1997.
22. Liu SF, Ye X, and Malik AB. Inhibition of NF-κB activation by pyrrolidine dithiocarbamate prevents in vivo expression of proinflammatory genes. Circulation 100: 1330-1337, 1999.
23. Liu SF, Ye X, and Malik AB. Pyrrolidine dithiocarbamate prevents IκB degradation and reduces microvascular injury induced by lipopolysaccharide in multiple organs. Mol Pharmacol 55: 658-667, 1999.
24. Lu Y, Parkyn L, Otterbein LE, Kureishi Y, Ray A, and Ray P. Activated Akt protects the lung from oxidant-induced injury and delays death of mice. J Exp Med 193: 545-549, 2001.
25. Luyet C, Burri PH, and Schittny JC. Suppression of cell proliferation and programmed cell death by dexamethasone during postnatal lung development. Am J Physiol Lung Cell Mol Physiol 282: L477-L483, 2002.
26. Meduri GU and Kanangat S. Glucocorticoid treatment of sepsis and acute respiratory distress syndrome. Time for a critical reappraisal. Crit Care Med 26: 630-633, 1998.
27. Munford RS and Pugin J. Normal responses to injury prevent systemic inflammation and can be immunosuppressive. Am J Respir Crit Care Med 163: 316-321, 2001.
28. Nathens AB, Bitar R, Davreux C, Bujard M, Marshall JC, Dackiw AP, Watson R, and Rotstein OD. Pyrrolidine dithiocarbamate attenuates endotoxin-induced acute lung injury. Am J Respir Cell Mol Biol 17: 608-616, 1997.
29. Newton R. Molecular mechanisms of glucocorticoid action: What is important? Thorax 55: 603-613, 2000.
30. Parrish D, Mitchell BC, Henson PM, and Larsen GL. Pulmonary response of the fifth component of complement-sufficient and -deficient mice to hyperoxia. J Clin Invest 74: 956-965, 1984.
31. Piette J, Piret B, Bonizzi G, Schoonbrodt S, Merville MP, Legrand-Poels S, and Bours V. Multiple redox regulation in NF-κB transcription factor activation. Biol Chem 378: 1237-1245, 1997.
32. 2-integrin modulates platelet caspase activation and life span in mice. Eur J Cell Biol 80: 1-7, 2001.
33. Rahman I, Mulier B, Gilmour PS, Watchorn T, Donaldson K, Jeffery PS, and MacNee W. Oxidant-mediated lung epithelial cell tolerance: The role of intracellular glutathione and nuclear factor-κB. Biochem Pharmacol 62: 787-794, 2001.
34. Sadikot RT, Jansen ED, Blackwell TR, Zoia O, Yull F, Christman JW, and Blackwell TS. High-dose dexamethasone accentuates nuclear factor-κB activation in endotoxin-treated mice. Am J Respir Crit Care Med 164: 873-878, 2001.
35. Salmon M, Koto H, Lynch OT, Haddad EB, Lamb NJ, Quinlan GJ, Barnes PJ, and Chung KF. Proliferation of airway epithelium after ozone exposure: Effect of apocynin and dexamethasone. Am J Respir Crit Care Med 157: 970-977, 1998.
36. Scheinman RI, Cogswell PC, Lofquist AK, and Baldwin AS Jr. Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids. Science 270: 283-286, 1995.
37. Schneider A, Martin-Villalba A, Weih F, Vogel J, With T, and Schwaninger M. NF-κB is activated and promotes cell death in focal cerebral ischemia. Nat Med 5: 554-559, 1999.
38. Seyle H. Thymus and adrenals in response of the organism to injuries and intoxication. Br J Exp Pathol 17: 234-248, 1936.
39. Suzuki C, Okano A, Takatsuki F, Myasaka Y, Hirano T, Kishimoto T, Ejima D, and Akiyama Y. Continuous perfusion with IL-6 enhances production of hematopoietic stem cells (CFUS). Biochem Biophys Res Commun 159: 933-938, 1989.
40. Vaisse C, Halaas JL, Horvath CM, Stoffel M, and Friedman JM. Leptin activation of Stat3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice. Nat Genet 14: 95-97, 1996.
41. Van den Berghe W, Vermeulen L, De Wilde G, De Bosscher K, Boone E, and Haegeman G. Signal transduction by tumor necrosis factor and gene regulation of the inflammatory cytokine interleukin-6. Biochem Pharmacol 8: 1185-1195, 2000.
42. Walker CD, Sizonenko PC, and Aubert ML. Modulation of the neonatal pituitary and adrenocortical responses to stress by thyroid hormones in the rat: Effects of hypothyroidism and hyperthyroidism. Neuroendocrinology 50: 265-273, 1989.
43. Ward N, Waxman A, Homer R, Mantell L, Einarsson O, Du Y, and Elias JA. IL-6-induced protection in hyperoxic acute lung injury. Am J Respir Cell Mol Biol 22: 535-542, 2000.
44. Wong HR, Odoms KK, Denenberg AG, Allen GL, and Shanley TP. Hyperoxia prolongs tumor necrosis factor-α-mediated activation of NF-κB: Role of IκB kinase. Shock 17: 274-279, 2002.
45. Wyllie AH and Morris RG. Hormone-induced cell death. Purification and properties of thymocytes undergoing apoptosis after glucocorticoid treatment. Am J Pathol 109: 78-87, 1982.